XTX Topco’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3K Buy
+14,648
New +$10.4K ﹤0.01% 4024
2026
Q1
Sell
-24,073
Closed -$23.6K 4133
2025
Q4
$23.6K Buy
24,073
+5,298
+28% +$6.99K ﹤0.01% 3024
2025
Q3
$28.5K Buy
+18,775
New +$33.4K ﹤0.01% 2271
2025
Q1
Sell
-569
Closed -$5.03K 2794
2024
Q4
$5.03K Buy
+569
New +$6.28K ﹤0.01% 2197
2024
Q3
Sell
-345
Closed -$8.17K 2389
2024
Q2
$8.17K Buy
+345
New +$6.56K ﹤0.01% 1709
2022
Q1
Sell
-68
Closed -$85K 842
2021
Q4
$85K Buy
+68
New +$110K 0.05% 489

Other funds holding MBIO

XTX Topco's MBIO Position: Q2 2026 in Review

XTX Topco opened a new position in Mustang Bio (MBIO) in Q2 2026: 14,648 shares worth $10.3K. The stake represents ﹤0.01% of the portfolio and ranks #4024 among its holdings. This is a return to the name: XTX Topco previously reported a position in MBIO as recently as Q4 2025.

XTX Topco first reported a position in MBIO in Q4 2021 and has held it in 6 quarters since. The position peaked at $85K in Q4 2021. 23 funds tracked by Wall St. Rank hold MBIO as of Q2 2026.

  • XTX Topco held 14,648 shares of Mustang Bio worth $10.3K as of Q2 2026.
  • Mustang Bio was a new XTX Topco position in Q2 2026.
  • Mustang Bio made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #4024 holding.
  • XTX Topco first reported a position in Mustang Bio in Q4 2021 and has held it in 6 quarters since.
  • XTX Topco's Mustang Bio position peaked at $85K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.